Clinical Trial Update: A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via the TWISTHALER® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging trial evaluating four doses of indacaterol delivered via the TWISTHALER device in chronic obstructive pulmonary disease; results are posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Indacaterol (indacaterol)

Snippet

Sponsor: Novartis | Conditions: COPD | Phase 2 | Status: COMPLETED | Results posted: 2013-01-18